$CME

CME Crypto Derivatives Trading Volume Reaches $469.5B in Q3

CME Group reported $469.5B in crypto derivatives trading volume in Q3 2026, with Bitcoin and Ether products leading. The company also achieved record quarterly revenue of $1.74B, up 13% YoY, with net income of $1B. Average daily trading volume across all asset classes reached 29.4M contracts.

Original reporting
Published Oct 23, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 5:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$CMEBullishMed
01

Why it matters

The data underscores CME's expanding role in crypto markets, which may drive investor interest in the stock.

02

Market read

CME's strong crypto derivatives performance could support its stock price and signal broader institutional crypto adoption.

03

What to watch

Potential competition from other futures exchanges and the impact of crypto price volatility on CME's fee revenue.

Relevance 8/10Novelty 8/10Timing: today

Background

CME Group disclosed its Q3 2026 crypto derivatives volume and revenue, marking a record quarter for the segment.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 2026 crypto derivatives notional volume of $469.5B and record quarterly revenue of $1.74B.

Expected impact

likely modest upside as investors price in higher fee revenue from crypto derivatives

Evidence & confidence

Quarterly volume and revenue beat expectations, indicating revenue tailwinds for CME's trading business.

Market effects

Boosts outlook for exchange‑traded crypto derivatives and related fintech services.

Positive for U.S. trading venues; may attract more institutional crypto activity.

Highlights growing global demand for regulated crypto futures, influencing other exchanges.

Counterpoint

If regulatory scrutiny on crypto intensifies, CME's volume could stall despite short‑term growth.

Key entities

  • CME Group

    U.S.-listed exchange reporting record crypto derivatives volume.

Related articles

$CMEMedAI 9/10

Key facts: CME Q3 Up; Adds BCH & UNI Futures; Crypto Revenue Embedded

CME Group (CME) reported Q3 2026 revenue of $1.74B (+13%), net income of $1.04B, and diluted EPS of $2.89 (+16%). The company launched Bitcoin Cash and Uniswap futures on Oct 19, 2026, and noted record average daily volume. Crypto revenue is embedded within broader market activities. CME also highlighted regional copper pricing divergences and 24/7 crypto trading volumes.

$CMEMedAI 8/10

CME Posts Record Q3 Revenue As Crypto Derivatives Push Continues

CME Group reported record Q3 revenue of $1.74B, up 13% YoY, with average daily volume at 29.4M contracts. Market-data revenue reached $243M. The company expanded its crypto offerings, announcing Bitcoin Cash and Uniswap futures, but did not disclose crypto-specific revenue. According to CME, first-half crypto derivatives volume averaged 279,800 contracts, with $8.3B in notional value.

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.